Skip to main content

Day: April 20, 2023

Lithium Americas Completes Acquisition of Arena Minerals

VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) — Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the “Company”) and Arena Minerals Inc. (TSX-V:AN) (“Arena”) are pleased to announce the completion of the previously announced plan of arrangement (the “Arrangement”) whereby Lithium Americas has acquired all of the issued and outstanding common shares of Arena. Arena owns 65% of the Sal de la Puna project covering approximately 13,200 hectares of the Pastos Grandes basin located in Salta, Argentina. “With the completion of the acquisition, we have taken a big step towards consolidating the Pastos Grandes basin,” said John Kanellitsas, Vice Chairman of Lithium Americas. “While our focus remains on near-term startup of production at Caucharí-Olaroz, the addition of Arena...

Continue reading

IMCD strengthens its minerals and chemicals portfolio for the coatings and paper industry with the acquisition of ACM AB

Main visual_IMCD strengthens its minerals and chemicals portfolio for the coatings and paper industry with the acquisition of ACM AB Standing, from left to right: Frank Schneider, Director Coatings & Construction IMCD Group; Emil Engvall, Managing Director ACM; and Jonas Langner, Finance Director IMCD Sweden Sitting, from left to right: Sami Valkama, Managing Director IMCD Sweden; Bengt Wigermo, Owner ACM; Xoan Au, Business Unit Manager Coatings & Construction IMCD Sweden; Tommy Petersson, Owner ACM, and Fenna Van Zanten, Global Director M&A IMCD GroupROTTERDAM, The Netherlands (20 April 2023) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Sweden has acquired 100% of the share capital of ACM AB (“ACM”), a distributor of minerals and chemicals. Established...

Continue reading

Rakovina Therapeutics Announces Presentation of New kt-3000 Series Data at AACR Annual Meeting

VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (the “Company”) (TSXV:RKV) today announced the presentation of new data describing the progress of the Company’s kt-3000 drug development program at the American Association of Cancer Research (AACR) annual meeting in Orlando, Florida. The Company’s data was presented in the DNA Damage Response section at the AACR annual meeting in a poster entitled “A novel bi-functional agent targeting PARP and HDAC in Ewing sarcoma”. Ewing sarcoma is a highly aggressive bone and soft tissue tumor affecting mainly children and young adults, with a dismal 5-year survival rate of 15-30% for metastatic disease. Previous studies have demonstrated that Ewing sarcoma cells are sensitive to FDA-approved PARP inhibitors, but clinical trials have failed to produce...

Continue reading

ProStar Announces Integration of its Leading Utility Mapping Solutions Software with ImpulseRadar’s Ground Penetrating Radar Utility Locating Technology

GRAND JUNCTION, Colo., April 20, 2023 (GLOBE NEWSWIRE) — ProStar Holdings Inc. (“ProStar®” or “the Company”) (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00) and ImpulseRadar joined resources to provide a more precise location subsurface utility mapping solution by integrating ProStar’s Precision Mapping Solutions™ PointMan® and ImpulseRadar’s world-leading PinPointR Ground Penetrating Radar (GPR) technology. “The industry is changing and moving away from standalone systems toward more integrated solutions,” stated Matthew Wolf, President of ImpulseRadar USA, Inc. “That means in our efforts to continue to be a Global leader and to satisfy our customer’s needs, we are eager to work with the leading technology providers that offer value-added software solutions. PointMan fits that...

Continue reading

Génomique | Thérapies Cellulaires & Génétiques | Bioproduction – RÉSULTATS ANNUELS 2022

GÉNOMIQUE | THÉRAPIES CELLULAIRES & GÉNÉTIQUES | BIOPRODUCTION                  RÉSULTATS ANNUELS 2022Revenus de l’activité 2022 en hausse de 5% à 1,5 M€ Maîtrise des charges opérationnelles courantes et des phases d’investissementRenforcement de la Direction pour mettre en œuvre le plan stratégiqueBagneux (France) – Genomic Vision (FR0011799907 – GV, la « Société »), société de biotechnologie cotée sur Euronext développant des produits et services dédiés à l’analyse et au contrôle des modifications du génome, publie aujourd’hui ses résultats financiers annuels au 31 décembre 20221. Résultats annuels 2022(en milliers d’euros – données IFRS) 2022 2021Chiffre d’affaires 1026 994Autres revenus 455 419Total revenus de l’activité 1 481 1 413Charges opérationnelles courantes -7 537 -6 274Résultat opérationnel...

Continue reading

Ascot Closes C$4.0 Million Non-Brokered Flow Through Private Placement

VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) is pleased to announce that pursuant to its news release dated April 12, 2023, the C$4.0 million non-brokered flow through private placement (the “Offering”) has been closed. The Offering raised total gross proceeds of C$4,050,000 and consisted of 5,000,000 common shares of the Company, which qualify as “flow-through shares” within the meaning of the Income Tax Act (Canada) (the “FT Shares”), at a price of C$0.81 per FT Share. The proceeds from the Offering will be used to fund the 2023 exploration program at the Company’s Premier Gold Project (“PGP” or the “project”), located on Nisga’a Nation Treaty Lands in the prolific Golden Triangle of northwestern British Columbia. The gross...

Continue reading

Aerojet Rocketdyne to Provide Additional Armor-Piercing Components for M1 Abrams Main Battle Tank Rounds

U.S. Army photo of M1A2 Abrams tank U.S. Army photo of M1A2 Abrams tank live fire by SFC Alan BrutusJONESBOROUGH, Tenn., April 20, 2023 (GLOBE NEWSWIRE) — Aerojet Rocketdyne’s specialty metal provider Aerojet Ordnance Tennessee (AOT) has been awarded a multi-year Indefinite Delivery Indefinite Quantity contract worth up to $75 million by the Army’s Project Manager for Maneuver Ammunitions Systems to provide M829A4 120mm Kinetic Energy round components. The M829A4 is an Armor-Piercing, Fin-Stabilized, Discarding-Sabot, Tracer round fired from the U.S. Army’s M1 Abrams Main Battle Tank. “We are pleased to continue supporting the Army with the cutting-edge, armor-piercing technology that protects our forces and keeps our adversaries on the defensive,” said Eileen P. Drake, Aerojet Rocketdyne CEO and president. “In terms of precision...

Continue reading

2022 Earnings Report

A transition year with a return to double-digit growth in the 4th quarterSustained growth in the Benelux and other countries, operational and management structures reinforced Operational transition in France while maintaining a structure capable of quickly seizing opportunities as the market consolidates Revenue up for the year: €904.6 million Adjusted EBITDA: €46.7 millionA solid balance sheet to support a new phase of growthNet cash position: €54.0 million Free cash flow: €37.2 millionStrong long-term outlook confirmedStructurally promising drivers of growth: the digital transformation and the energy transition Continued strong growth in the Benelux and other countries where new markets are opening up Sights set to exceed €1 billion in revenue for 2023Solutions30 SE today announces its consolidated earnings for the financial...

Continue reading

EssilorLuxottica: Q1 2023 Revenue – Solid start to the year

Q1 2023 Revenue Solid start to the yearGroup’s revenue at Euro 6,151 million, up 9.7% vs 2022 Growing 8.6% at constant exchange rates1 versus the best quarter of last year North America and EMEA up high-single digit1, APAC and Latin America up double digits1 All regions accelerating1 versus the fourth quarter of last year Comparable-store sales2growing high-single digit, with former GV banners outpacing Commitment to set near-term science-based emissions reduction targets in line with SBTiCharenton-le-Pont, France (April 20, 2023 – 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the first quarter of 2023 reached Euro 6,151 million, representing a year-on-year increase of 8.6% at constant exchange rates1 compared to the first quarter of 2022 (+9.7% at current exchange rates). Francesco Milleri, Chairman...

Continue reading

Q1 2023 revenue: Sales growth +2.0% upheld by price increases implemented in 2022 Excellent performance of Sport offsetting slower demand in flooring

Q1 2023 revenue: Sales growth +2.0% upheld by price increases implemented in 2022 Excellent performance of Sport offsetting slower demand in flooring Results for the first quarter 2023Revenue up +2.0% compared to Q1 2022, benefiting from sales price increases deployed in 2022 and a favourable foreign exchange effect, offsetting the decline in volume Excellent level of activity in Sport: organic growth of +17.8% compared with Q1 2022 Business volume down in EMEA compared to Q1 2022 due to continuing weakness in residential demand, tempered by the good resistance of commercial products In North America, slight decline in Commercial activity, recovery in Hospitality and marked decrease in volume in Residential Stabilisation of activity level in CIS around -20% compared with 2022, slow start to the year in Asia but continued growth in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.